Clinical trial phases, explained: what phase 1, 2, 3 and 4 tell you
Phase labels appear in every drug-pipeline headline. Here is what each phase is designed to answer, how large the studies typically are, and what a phase label does not tell you.
The signal
FDA describes four phases of clinical research: phase 1 focuses on safety and dosage, phase 2 on efficacy and side effects, phase 3 on efficacy and monitoring of adverse reactions in larger groups, and phase 4 on safety and efficacy after approval.
Why this matters
Pipeline news is easier to weigh when you know what stage a study is at: an early-phase result answers different questions from a large phase 3 trial, and every therapy still in trials is investigational.
NPHLA takeaway
Read a phase label as a description of the study, not a verdict on the drug. Results from any phase need the full published data, and approval decisions come only from FDA. General information, not medical advice.
Source file
- [1]
- [2]
Drafted with AI assistance from the sources listed in the Source File, then reviewed and approved by an NPHLA editor before publication. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.